COREGEN

CoRegen is a biopharmaceutical company exploiting its revolutionary master gene regulator platform to treat cancer and other malignant and high intensity chronic illnesses. Although the CoRegen platform has a wide range of potential therapies it will initially focus on select cancers... CoRegen's approach targets the expression of multiple immune checkpoint target genes, leading to a superior anti-tumor effect when compared to exiting single-target immune checkpoint biologic drugs... Our novel approach has the potential to more effectively treat multiple types of cancer-without toxicity, inflammation, or off-target effects

Primary location: Houston United States